SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.

The molecular determinants that render specific populations of normal cells susceptible to oncogenic reprogramming into self-renewing cancer stem cells are poorly understood. Here, we exploit T-cell acute lymphoblastic leukemia (T-ALL) as a model to define the critical initiating events in this dise...

Full description

Bibliographic Details
Main Authors: Bastien Gerby, Cedric S Tremblay, Mathieu Tremblay, Shanti Rojas-Sutterlin, Sabine Herblot, Josée Hébert, Guy Sauvageau, Sébastien Lemieux, Eric Lécuyer, Diogo F T Veiga, Trang Hoang
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-12-01
Series:PLoS Genetics
Online Access:http://europepmc.org/articles/PMC4270438?pdf=render
_version_ 1818994737945772032
author Bastien Gerby
Cedric S Tremblay
Mathieu Tremblay
Shanti Rojas-Sutterlin
Sabine Herblot
Josée Hébert
Guy Sauvageau
Sébastien Lemieux
Eric Lécuyer
Diogo F T Veiga
Trang Hoang
author_facet Bastien Gerby
Cedric S Tremblay
Mathieu Tremblay
Shanti Rojas-Sutterlin
Sabine Herblot
Josée Hébert
Guy Sauvageau
Sébastien Lemieux
Eric Lécuyer
Diogo F T Veiga
Trang Hoang
author_sort Bastien Gerby
collection DOAJ
description The molecular determinants that render specific populations of normal cells susceptible to oncogenic reprogramming into self-renewing cancer stem cells are poorly understood. Here, we exploit T-cell acute lymphoblastic leukemia (T-ALL) as a model to define the critical initiating events in this disease. First, thymocytes that are reprogrammed by the SCL and LMO1 oncogenic transcription factors into self-renewing pre-leukemic stem cells (pre-LSCs) remain non-malignant, as evidenced by their capacities to generate functional T cells. Second, we provide strong genetic evidence that SCL directly interacts with LMO1 to activate the transcription of a self-renewal program coordinated by LYL1. Moreover, LYL1 can substitute for SCL to reprogram thymocytes in concert with LMO1. In contrast, inhibition of E2A was not sufficient to substitute for SCL, indicating that thymocyte reprogramming requires transcription activation by SCL-LMO1. Third, only a specific subset of normal thymic cells, known as DN3 thymocytes, is susceptible to reprogramming. This is because physiological NOTCH1 signals are highest in DN3 cells compared to other thymocyte subsets. Consistent with this, overexpression of a ligand-independent hyperactive NOTCH1 allele in all immature thymocytes is sufficient to sensitize them to SCL-LMO1, thereby increasing the pool of self-renewing cells. Surprisingly, hyperactive NOTCH1 cannot reprogram thymocytes on its own, despite the fact that NOTCH1 is activated by gain of function mutations in more than 55% of T-ALL cases. Rather, elevating NOTCH1 triggers a parallel pathway involving Hes1 and Myc that dramatically enhances the activity of SCL-LMO1 We conclude that the acquisition of self-renewal and the genesis of pre-LSCs from thymocytes with a finite lifespan represent a critical first event in T-ALL. Finally, LYL1 and LMO1 or LMO2 are co-expressed in most human T-ALL samples, except the cortical T subtype. We therefore anticipate that the self-renewal network described here may be relevant to a majority of human T-ALL.
first_indexed 2024-12-20T21:02:43Z
format Article
id doaj.art-b02922aa59b74cc7982008ea73a621e7
institution Directory Open Access Journal
issn 1553-7390
1553-7404
language English
last_indexed 2024-12-20T21:02:43Z
publishDate 2014-12-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Genetics
spelling doaj.art-b02922aa59b74cc7982008ea73a621e72022-12-21T19:26:41ZengPublic Library of Science (PLoS)PLoS Genetics1553-73901553-74042014-12-011012e100476810.1371/journal.pgen.1004768SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.Bastien GerbyCedric S TremblayMathieu TremblayShanti Rojas-SutterlinSabine HerblotJosée HébertGuy SauvageauSébastien LemieuxEric LécuyerDiogo F T VeigaTrang HoangThe molecular determinants that render specific populations of normal cells susceptible to oncogenic reprogramming into self-renewing cancer stem cells are poorly understood. Here, we exploit T-cell acute lymphoblastic leukemia (T-ALL) as a model to define the critical initiating events in this disease. First, thymocytes that are reprogrammed by the SCL and LMO1 oncogenic transcription factors into self-renewing pre-leukemic stem cells (pre-LSCs) remain non-malignant, as evidenced by their capacities to generate functional T cells. Second, we provide strong genetic evidence that SCL directly interacts with LMO1 to activate the transcription of a self-renewal program coordinated by LYL1. Moreover, LYL1 can substitute for SCL to reprogram thymocytes in concert with LMO1. In contrast, inhibition of E2A was not sufficient to substitute for SCL, indicating that thymocyte reprogramming requires transcription activation by SCL-LMO1. Third, only a specific subset of normal thymic cells, known as DN3 thymocytes, is susceptible to reprogramming. This is because physiological NOTCH1 signals are highest in DN3 cells compared to other thymocyte subsets. Consistent with this, overexpression of a ligand-independent hyperactive NOTCH1 allele in all immature thymocytes is sufficient to sensitize them to SCL-LMO1, thereby increasing the pool of self-renewing cells. Surprisingly, hyperactive NOTCH1 cannot reprogram thymocytes on its own, despite the fact that NOTCH1 is activated by gain of function mutations in more than 55% of T-ALL cases. Rather, elevating NOTCH1 triggers a parallel pathway involving Hes1 and Myc that dramatically enhances the activity of SCL-LMO1 We conclude that the acquisition of self-renewal and the genesis of pre-LSCs from thymocytes with a finite lifespan represent a critical first event in T-ALL. Finally, LYL1 and LMO1 or LMO2 are co-expressed in most human T-ALL samples, except the cortical T subtype. We therefore anticipate that the self-renewal network described here may be relevant to a majority of human T-ALL.http://europepmc.org/articles/PMC4270438?pdf=render
spellingShingle Bastien Gerby
Cedric S Tremblay
Mathieu Tremblay
Shanti Rojas-Sutterlin
Sabine Herblot
Josée Hébert
Guy Sauvageau
Sébastien Lemieux
Eric Lécuyer
Diogo F T Veiga
Trang Hoang
SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
PLoS Genetics
title SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
title_full SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
title_fullStr SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
title_full_unstemmed SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
title_short SCL, LMO1 and Notch1 reprogram thymocytes into self-renewing cells.
title_sort scl lmo1 and notch1 reprogram thymocytes into self renewing cells
url http://europepmc.org/articles/PMC4270438?pdf=render
work_keys_str_mv AT bastiengerby scllmo1andnotch1reprogramthymocytesintoselfrenewingcells
AT cedricstremblay scllmo1andnotch1reprogramthymocytesintoselfrenewingcells
AT mathieutremblay scllmo1andnotch1reprogramthymocytesintoselfrenewingcells
AT shantirojassutterlin scllmo1andnotch1reprogramthymocytesintoselfrenewingcells
AT sabineherblot scllmo1andnotch1reprogramthymocytesintoselfrenewingcells
AT joseehebert scllmo1andnotch1reprogramthymocytesintoselfrenewingcells
AT guysauvageau scllmo1andnotch1reprogramthymocytesintoselfrenewingcells
AT sebastienlemieux scllmo1andnotch1reprogramthymocytesintoselfrenewingcells
AT ericlecuyer scllmo1andnotch1reprogramthymocytesintoselfrenewingcells
AT diogoftveiga scllmo1andnotch1reprogramthymocytesintoselfrenewingcells
AT tranghoang scllmo1andnotch1reprogramthymocytesintoselfrenewingcells